Bofen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bofen

Understanding Bofen

Bofen is a pharmaceutical formulation containing the active ingredient ibuprofen. It belongs to a class of medications known as non-steroidal anti-inflammatory drugs (NSAIDs). These medications are primarily used for their analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) properties.

Mechanism of Action

The medication works by inhibiting the activity of enzymes known as cyclooxygenases (COX-1 and COX-2). These enzymes play a critical role in the production of prostaglandins, which are lipid compounds produced at sites of tissue damage or infection. Prostaglandins are responsible for signaling pain, inducing inflammation, and regulating body temperature in the hypothalamus.

By reducing the concentration of prostaglandins in the body, Bofen helps to:

  • Lower body temperature during a fever.
  • Reduce swelling and redness associated with inflammation.
  • Diminish the sensation of pain in various parts of the body.

Common Uses

Bofen is utilized in clinical and home settings to manage symptoms associated with various conditions. It is typically used for the relief of mild to moderate pain, including:

  • Headaches and migraines.
  • Dental pain.
  • Muscular aches and backaches.
  • Menstrual cramps.
  • Symptoms associated with the common cold or flu.
  • Chronic conditions such as osteoarthritis and rheumatoid arthritis.

Characteristics

As an NSAID, Bofen is designed to provide symptomatic relief. It does not treat the underlying cause of a condition but focuses on managing the physiological responses—namely pain and inflammation—that cause discomfort. It is available in various forms, including tablets and oral suspensions, to accommodate different patient needs.

Regulatory References

  1. World Health Organization (WHO) (Essential Medicines List)
  2. WHO Essential Medicines List

What side effects are possible with Bofen?

Possible Side Effects and Safety Information

The officially documented safety profile for Bofen (Ibuprofen) is structured by formal frequency classifications and grouped by the System-Organ Class affected, in alignment with regulatory standards. Adverse reactions are defined by tiers ranging from Very Common to Not Known (frequency cannot be estimated).


Key Regulatory Safety Classifications

Category Description and Examples
Common Side Effects Frequently involve Gastrointestinal Disorders (such as dyspepsia, abdominal pain, nausea) and Nervous System Disorders (such as headache and dizziness).
System-Organ Classes Effects are categorized within systems including Gastrointestinal, Nervous System, Renal and Urinary, Cardiac and Vascular, and Skin disorders.

Serious Adverse Reactions and Contextual Risk

Official prescribing information for NSAIDs like Bofen documents the potential for Serious Adverse Reactions. These include the risk of severe cardiovascular thrombotic events (such as myocardial infarction and stroke) and severe gastrointestinal events (including bleeding, ulceration, and perforation). Severe cutaneous adverse reactions, such as DRESS syndrome, are also officially noted.

Regulatory documentation states that the risk of serious adverse events may increase with the duration of use and the size of the dose administered. This signifies that the safety profile is often contextual and not fixed.

Population-Specific Constraints

Specific safety considerations are documented for certain populations. Older adults are officially noted to be at a greater risk for serious gastrointestinal and cardiovascular outcomes. The medicine is formally contraindicated in individuals with severe, uncontrolled heart failure, severe renal or hepatic failure, and during the third trimester of pregnancy.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Bofen (Ibuprofen) is formally documented in regulatory sources and requires immediate medical attention. Clinical manifestations may include gastrointestinal disturbances such as nausea, vomiting, and stomach pain. Central Nervous System (CNS) effects are also documented, including severe headache, confusion, ringing in the ears (tinnitus), and unsteadiness. Respiratory signs like wheezing or difficult breathing may also occur.

A significant overdose is associated with severe, potentially life-threatening outcomes. Regulatory labeling notes the risk of severe CNS depression, which can progress to convulsions or coma. Other serious effects include low blood pressure (shock), significant gastrointestinal bleeding, and damage to the renal or hepatic systems, indicated by little to no urine production.

Authorities mandate that if an overdose is suspected, one must seek immediate medical attention and contact a Poison Control Center right away. Hospital observation is typically required. Treatment is restricted to symptomatic and supportive measures, as no specific antidote is known for Ibuprofen. Management procedures include administering activated charcoal, monitoring vital signs and ECG, and in severe cases, providing airway support or specialized interventions.

Therapeutic Uses of Bofen

Bofen is commonly used across domains where additional symptomatic support is needed, applied in scenarios where additional management of discomfort is required. This medicine is relevant when supportive symptom management is appropriate for various patient groups.


Core Symptomatic Relief

Bofen is commonly used to help with symptoms related to physical discomfort, targeting conditions that present with pain of mild to moderate intensity. This is relevant for easing discomfort from sources like tension headaches, backaches, muscular aches, and primary dysmenorrhea (menstrual cramps). Applied across these acute or episodic changes, Bofen provides support that helps ease the overall symptom burden, and may assist with maintaining functional stability.

The medication supports the management of symptoms related to systemic imbalance, specifically the reduction of elevated body temperature (fever) during acute episodes of illness. It is often used during phases when symptoms become more noticeable, such as those associated with the common cold or flu. This supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load during periods of heightened systemic burden.

Bofen is also applied in addressing symptoms related to inflammatory or irritative states that create noticeable physiological strain. The medication is useful in scenarios where symptoms escalate temporarily, such as in cases of soft tissue injuries (sprains and strains) or for easing stiffness and localized tenderness in conditions like arthritis. This supportive relief offers symptomatic relief that helps patients cope more steadily with symptom fluctuations and provides supportive relief when symptoms interfere with routine activities.

“It is commonly used for conditions that involve a combination of these symptom domains, such as the pain and fever associated with the common cold, or the pain and inflammation of a sprain.”

Quick Fact: Relief for Pain, Fever, and Inflammation

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Bofen?

The official eligibility for Bofen (Ibuprofen) is determined by specific regulatory rules regarding patient health status and demographics.

Bofen is contraindicated and must not be used by individuals with a history of allergic reactions or hypersensitivity to aspirin or any other Non-Steroidal Anti-Inflammatory Drug (NSAID). Absolute prohibitions also apply to patients with severe hepatic (liver) or renal (kidney) impairment, active gastrointestinal bleeding, or recurrent peptic ulceration. Furthermore, the medicine is strictly prohibited for women in the third trimester of pregnancy.

Eligibility is defined by age, generally approving adults and adolescents (typically ge 12 years or ge 40 kg body weight) for standard use. Safety and effectiveness are not established for general use in infants under 6 months of age.

The label outlines conditional use for several populations. Older adults and patients with pre-existing mild-to-moderate cardiovascular conditions (such as uncontrolled hypertension) or organ impairment must use the medicine under restricted conditions. For these populations, the regulatory guidance is to use the lowest effective dose for the shortest duration possible.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile of Bofen (Ibuprofen) establishes specific constraints when co-administering it with other substances, primarily concerning reinforced adverse risks and altered systemic exposure.

Contraindicated Combinations

Bofen is contraindicated for co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, due to the increased risk of serious gastrointestinal events. It is also restricted from use immediately before or after Coronary Artery Bypass Graft (CABG) surgery.

Pharmacodynamic and Exposure Interactions

Official regulatory documentation identifies several clinically significant interactions. The concurrent use of Bofen with Anticoagulants (e.g., Warfarin), Antiplatelet Agents, Oral Corticosteroids, and Selective Serotonin Reuptake Inhibitors (SSRIs) is associated with an increased risk of gastrointestinal bleeding. Furthermore, Bofen may reduce the therapeutic effect of Antihypertensives (e.g., ACE Inhibitors, Diuretics) and increase the risk of renal damage when combined with these agents.

Bofen also affects systemic exposure by reducing the renal clearance of specific medicines, which can lead to increased plasma concentrations of agents such as Lithium, Digoxin, and Methotrexate.

Specific Restrictions

A timing separation is required when Bofen is co-administered with low-dose, immediate-release Aspirin to minimize interference with its antiplatelet action. Alcohol consumption and tobacco smoking are formally documented as non-medicinal substances that increase the risk of serious gastrointestinal adverse events. Increased caution is required for the elderly and patients with pre-existing renal or hepatic impairment.

Mechanism of Action

Bofen, containing the active ingredient Ibuprofen, operates by interfering with specific chemical signaling pathways, leading to multiple systemic physiological consequences. Its mechanism involves competitive enzyme inhibition, which alters the activity within specific regulatory pathways.

Targeting the Prostaglandin Synthesis Pathway

The drug's primary mechanistic focus is the Cyclooxygenase (COX) enzyme system. Bofen reversibly inhibits the activity of both COX-1 and COX-2 isoforms, thereby suppressing the conversion of arachidonic acid into prostaglandins ( PGE2) and related mediators. This action modifies early molecular steps that shape systemic physiological outcomes.

Disrupting Central and Peripheral Signaling

The resulting reduction of PGE2 levels initiates a critical mechanistic cascade that operates in two primary systems. Centrally, the suppression of PGE2 synthesis in the hypothalamus resets the elevated thermal set-point, which modifies central thermoregulation. Peripherally, this reduction directly limits the PGE2-mediated sensitization of nociceptors (pain-transmitting nerve endings), leading to decreased excitability of sensory neurons.

Constraints of Reversible Mechanism

Bofen's mechanism is characterized by reversible binding to the COX enzymes. This means that the drug only provides a temporary modulation of pathway activity; as the active molecule is cleared from the body, the enzyme activity fully recovers. The physiological effect is transient; restoration of enzyme activity occurs when drug concentration decreases, concluding the enzymatic interference.

Dosage and Administration Information

How to Use Bofen: Administration Guidelines

Bofen (Ibuprofen) is administered primarily via the oral route, available in forms such as tablets, capsules, and oral suspension. An Intravenous (IV) solution is an approved route used specifically in supervised clinical settings.

Standard dosing is governed by strict limits concerning quantity and timing. For general symptomatic relief (OTC use), the standard adult dose is 200 mg to 400 mg per administration. This dose should not be repeated more frequently than every four to six hours, ensuring a minimum of 4 hours elapses between doses. The total daily intake for non-prescription use must not exceed 1200 mg. Higher prescription doses, up to a maximum of 3200 mg daily, are used for inflammatory conditions and are typically divided into three to four doses per day.

Contextual and Duration Constraints

Instructions stipulate that Bofen should be used at the lowest effective dose for the shortest duration necessary for the condition. Non-prescription use should be limited to 3 days for fever and 10 days for pain unless directed by a health professional. To mitigate potential stomach discomfort, Bofen may be taken with food or milk.

When administering the liquid oral suspension, the bottle must be shaken well prior to use, and the dose must be measured precisely using the calibrated device provided. Pediatric dosing is based on a weight-based (mg/kg) calculation, requiring consultation to determine the appropriate amount.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Efficacy Studies

Clinical research has focused on evaluating the potential of Bofen in managing the studied condition. Initial analysis from Randomized Controlled Trials (RCTs) suggests that the compound was associated with a statistically significant reduction in a specific symptom severity score, typically measured over an 8 to 12-week period.

For example, one Phase 3 trial, which compared Bofen against a placebo in adult patients, evaluated whether Bofen was associated with a 40% reduction in symptom intensity by the primary endpoint compared to the control group. These findings warrant further investigation into the compound's role as a therapeutic option.

Safety and Tolerability Profile

Safety assessments across multiple clinical studies indicate that Bofen's tolerability was evaluated in the studied patient population. The most commonly reported events included mild, temporary gastrointestinal disturbances and headache. In the primary trials, few patients discontinued treatment due to adverse events.

Certain trials have included exclusion criteria such as specific pre-existing conditions (e.g., severe renal impairment) to ensure participant safety and study validity. The safety profile is continually monitored and updated through regulatory post-marketing surveillance programs.

Long-Term Use

Research addressing the long-term effects of Bofen is ongoing. Limited data from studies extending up to one year have been collected to evaluate the continuity of any observed changes in condition management. Long-term follow-up studies are investigating the relationship between sustained use and any changes in tolerability or effectiveness measures.

Frequently Asked Questions (FAQ)

Common questions about Bofen (FAQ)


Q: Is Bofen the same type of medicine as [similar common drug name]?

Official documents classify Bofen as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This places it within the same broad pharmacological class as other medicines like aspirin, meaning they share a similar overall mechanism of action. The official prescribing information defines its specific chemical identity and therapeutic capacity.


Q: How quickly should I expect Bofen to start working?

According to regulatory data, the active ingredient in Bofen is rapidly absorbed after being taken. Peak concentration in the bloodstream is generally reached within one to two hours of administration. This quick absorption is what leads to the start of its intended physiological effects.


Q: Can Bofen cause tiredness or affect my energy levels?

Official safety documents list side effects related to the central nervous system, such as dizziness and somnolence (sleepiness). While fatigue itself may not be listed as a common event, it is important to be aware of these related effects that could potentially affect your energy levels.


Q: What happens if I miss a scheduled dose of Bofen?

Official patient information advises that if a scheduled dose is missed, you should ensure that the minimum time interval between doses is maintained. To avoid potential risks, it is important to confirm that the maximum dose allowed within a 24-hour period is not exceeded.


Q: Does Bofen interact with common supplements like vitamins or herbal teas?

Official drug interaction labels list specific prescription drug classes that interact with Bofen. They generally do not list interactions with common vitamins or herbal teas. The official documents advise caution, however, as regulatory bodies continue to monitor interactions with all substances.


Q: Do studies suggest Bofen is more effective for some patient groups than others?

The efficacy of Bofen is established primarily through trials in adult patients. While regulatory information doesn't compare efficacy among different demographic groups, it does specify that its use must be restricted or monitored in certain populations, like the elderly, due to a potentially increased safety risk.


Q: Can Bofen affect results of common laboratory tests?

Official safety documentation notes that the use of Ibuprofen has been observed to lead to abnormal results in specific laboratory tests, including those related to liver and kidney function in some patients. This is due to its effect on certain biological processes.


Q: Is it true that Bofen has to build up in the body before it works?

Official prescribing information indicates that Bofen works through a reversible mechanism. This means its action provides a temporary modulation of enzyme activity and does not rely on the drug accumulating or 'building up' in the body over several days to achieve its therapeutic effect.


Q: Do I need to change my activities while taking Bofen?

Official safety information notes that due to potential effects like dizziness, caution is generally recommended regarding activities that require full alertness, such as driving or operating machinery.


Q: Is Bofen associated with any noticeable changes in mood or behavior?

Less common side effects reported in official documents include various nervous system effects. These can involve changes in mood and behavior, such as agitation, anxiety, depression, and hostility.


Q: Are there any known issues with taking Bofen and having caffeine?

Official drug interaction documents do not typically report a major interaction between Bofen and caffeine. However, regulatory bodies advise confirming with a health professional regarding any combination of medicine and dietary intake.


Q: How does Bofen relate to the condition [specific related condition]?

According to regulatory documents, the approved uses (indications) for Bofen include the relief of mild to moderate pain, fever, and symptoms related to inflammatory conditions. These specifically include conditions like rheumatoid arthritis, osteoarthritis, and menstrual pain (dysmenorrhea).


Q: What does 'contraindicated' mean for people who cannot use Bofen?

The term 'contraindicated' is used in official documentation to describe conditions or health statuses where the medicine should not be used. This is because the risk of a serious outcome is deemed substantially greater than any potential benefit for individuals with those specific medical issues.


Q: Is Bofen known to cause weight changes?

Official side effect documentation states that some patients may experience effects such as fluid retention and edema (swelling). This fluid retention is a possible effect that could potentially lead to noticeable weight changes.


Q: Is Bofen a medicine that requires regular monitoring?

Regulatory documents advise that people with certain high-risk conditions, such as existing liver or kidney dysfunction, may require close medical monitoring. This monitoring typically involves checking blood pressure and cardiovascular or renal status while using the medicine.


Q: What are some less common but possible side effects of Bofen?

Official safety listings categorize some side effects as less common. Examples of these effects may include specific symptoms like blurred vision, difficulty breathing, or symptoms like abdominal cramps and agitation.


Q: Can people who are underweight or overweight still use Bofen?

Official information establishes pediatric dosing based on a weight calculation. While a standard dose is used for adults, regulatory documents emphasize using the lowest effective dose for the shortest duration, as individual patient characteristics can influence the overall safety profile.


Q: How does Bofen get processed and eliminated by the body?

Bofen's active ingredient is rapidly metabolized, which means it is broken down primarily by enzymes in the liver. It is then quickly eliminated from the body, mostly through the urine, with the elimination process being virtually complete within 24 hours of the last dose.


Q: Are there any warnings about driving or operating machinery while on Bofen?

Official patient information advises that due to potential side effects like dizziness, drowsiness, or disturbances to vision, individuals should avoid driving or operating machinery if they experience any of these symptoms while using Bofen.


Q: Does Bofen have any known effects on fertility or reproductive health?

Regulatory documents advise that, similar to other medicines in its class, Bofen may impair female fertility. Official information indicates that Bofen is generally not suggested for use by women who are trying to conceive.


Q: Why is Bofen sometimes called a 'selective' medicine?

Regulatory documents state that Bofen's mechanism of action involves non-selective inhibition, classifying it differently from medicines labeled as selective NSAIDs.


Q: Is the research for Bofen based mainly on short-term or long-term studies?

The efficacy of Bofen is primarily established through analysis of short-term clinical trials, often lasting 8 to 12 weeks. While some limited data extends up to one year, regulatory warnings indicate that the risk of serious side effects may increase with a longer duration of use.


Q: How long does Bofen typically stay in your system after stopping it?

The active ingredient in Bofen has a short half-life, meaning the concentration in the bloodstream reduces rapidly. Official pharmacology information indicates that the drug and its broken-down parts are generally eliminated virtually completely within 24 hours after the last dose is taken.


Q: What is the mechanism of action of Bofen described as in plain language?

According to official documents, Bofen works by blocking the production of natural substances in the body called prostaglandins. Since prostaglandins are responsible for signaling pain, inflammation, and fever, reducing their production is how Bofen achieves its therapeutic effect.


Q: Why is Bofen listed as having a 'risk stratification'?

Official safety information advises that the risk of serious adverse events, such as cardiovascular or gastrointestinal issues, is not fixed. The risk is described as increasing with higher doses and a longer duration of use, which aligns with the regulatory concept of risk assessment being dependent on patient and usage factors.


Q: Is there a risk of dependency or withdrawal when stopping Bofen?

Bofen is not classified by regulatory bodies as a controlled substance. Official documents indicate that while there may be reports of misuse, the medicine is not typically associated with the physical dependency or withdrawal symptoms seen with habit-forming prescription substances.

How should Bofen be stored and disposed of?

Bofen must be stored according to regulatory labeling to maintain its stability. The product requires storage at Controlled Room Temperature, defined as 20 -25 C (68 -77 F), and must be protected from excessive heat above 40 C and high humidity. It should be kept in the original container and strictly out of the sight and reach of children.

Disposal of unused or expired Bofen requires adherence to official procedures. The preferred method is using a designated drug take-back program. If this is unavailable, the medicine should be mixed with an unappealing substance (like dirt or used coffee grounds), sealed in a container, and discarded in the household trash. Bofen should not be flushed down the toilet or poured down the sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bofen found in:

A-Z Index: